Combination chemotherapy with docetaxel and irinotecan in metastatic malignant melanoma.

---

Atıf İçin Kopyala

Tas F., Camlica H., Kurul S., Aydiner A., Topuz E.

Clinical oncology (Royal College of Radiologists (Great Britain)), cilt.15, sa.3, ss.132-5, 2003 (SCI-Expanded)

• Yayın Türü: Makale / Tam Makale
• Cilt numarası: 15 Sayı: 3
• Basım Tarihi: 2003
• Doi Numarası: 10.1053/clon.2003.0205
• Dergi Adı: Clinical oncology (Royal College of Radiologists (Great Britain))
• Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
• Sayfa Sayıları: ss.132-5
• İstanbul Üniversitesi Adresli: Evet

Özet

Aim: The aim of the current trial was to assess the efficacy and toxicity of 3-weekly intravenous docetaxel and irinotecan in the treatment of patients with metastatic malignant melanoma.